Draegerwerk Earnings Call: Record Sales, Cautious Outlook

Draegerwerk AG & Co. KGaA (0MT8) ((DE:DRW8)) has held its Q4 earnings call. Read on for the main highlights of the call.

Draegerwerk AG & Co. KGaA struck an upbeat tone on its 2025 earnings call, highlighting record sales, sharply higher earnings and a stronger balance sheet despite sizable external headwinds. Management stressed that pricing, product mix and cost discipline more than offset tariffs, currency hits and the lack of prior one-offs, but also underlined that 2026 will bring higher investment and continued uncertainty.

Record Net Sales and Robust Order Momentum

Net sales climbed to a record around EUR 3.5 billion, up 5.3% on a currency‑adjusted basis and slightly ahead of guidance and pre‑pandemic 2020 levels. Order intake was even stronger, rising 7.7% to roughly EUR 3.6 billion, with both the Medical and Safety divisions and all major regions contributing to the growth.

EBIT and Margin Step-Up Despite External Headwinds

EBIT surged more than 20% to about EUR 233 million, lifting the Group EBIT margin to 6.7% from 5.8% and signaling solid operational leverage. Management emphasized that this improvement came even as tariffs, FX and missing one‑offs created more than EUR 90 million in opposing effects that had to be offset by internal measures.

Gross Margin Gains Driven by Medical Mix and Pricing

Group gross margin edged up 0.3 percentage points to 45.2%, supported mainly by a more favorable product and country mix in the Medical division. Pricing actions also helped defend profitability against persistent cost inflation and tariffs, showing the company’s ability to pass on part of its cost burden to customers.

Medical Division Delivers Turnaround

The Medical division posted an order intake increase of roughly 9% and net sales growth of 7.4%, with Q4 revenue up a strong 13%. Gross margin improved by 0.6 percentage points to 43.6%, and EBIT approximately doubled to EUR 57 million, lifting the EBIT margin from 1.5% to 2.9% and delivering a Q4 EBIT jump of about 40% to some EUR 80 million.

Safety Division Shows Resilience and Margin Strength

Safety continued to provide a profit backbone, with orders up more than 6% and net sales up 2.6% amid softer conditions in some markets. The division kept its gross margin stable at 47.3% while growing EBIT by 6.4% to roughly EUR 176 million, pushing the EBIT margin to 11.9% and achieving a standout Q4 EBIT margin of 16.5%.

Cash Generation and Balance Sheet Strengthen

Operating cash flow improved by around EUR 71 million to approximately EUR 238 million, translating into free cash flow of roughly EUR 140 million. Cash conversion was close to 100%, cash and equivalents rose to EUR 282 million and net financial debt dropped about 25% to EUR 123 million, reducing leverage to a comfortable 0.3x EBITDA.

Earnings per Share Recovery and Dividend Upside

Earnings per common share swung from a loss of about EUR 3.50 in 2022 to roughly EUR 7.40 in 2025, with preferred shares reaching EUR 7.50, underscoring a clear profitability recovery. Reflecting this, the company proposed sharply higher dividends of EUR 2.21 for common and EUR 2.27 for preferred shares, in line with its roughly 30% payout policy.

Share Price Outperformance and Index Inclusion

Investors have already rewarded the turnaround, with common shares gaining more than 33% and preferred shares about 50% over the period discussed. The preferred stock’s inclusion in TecDAX adds further visibility and may support liquidity, reinforcing the market’s improved perception of Draegerwerk’s equity story.

Strategic Wins and Innovation Drive Growth Options

Management highlighted progress in connectivity and systems, including SDC‑based solutions and a Silent Care Package, as well as new wins such as a Paris Fire Department contract for fire ground monitoring. The company also confirmed the growth trajectory of its defense business, which has surpassed EUR 100 million in sales and is targeted to exceed EUR 300 million by 2028.

Tariffs and Currency: Material Drags on EBIT

U.S. import tariffs cut 2025 EBIT by roughly EUR 26 million, with the Medical division bearing about EUR 21 million and Safety about EUR 5 million, and the tariff environment remains unpredictable. Adverse currency movements reduced EBIT by around EUR 45 million and are expected to continue to weigh in 2026, albeit with a smaller impact on sales and margins.

Offsetting Large Opposing Effects and Rising Costs

In total, lost one‑offs, tariffs and FX created more than EUR 90 million of negative effects year on year, forcing Draegerwerk to rely on price, mix and cost efficiency to protect profitability. Functional expenses rose 4.6%, or 2.5% excluding one‑offs, as personnel costs increased due to wage agreements and headcount growth, illustrating the ongoing cost pressure behind the numbers.

Operational Challenges in Q4 and Regional Pockets of Weakness

The Medical division’s Q4 gross margin slipped by 0.6 percentage points due to higher inventory write‑downs, partly offsetting the full‑year improvement and showing that execution risks remain. Regionally, Medical net sales in APAC were about 3% below the prior year, while Safety faced declines in the Americas and muted industrial demand in Germany, highlighting uneven demand patterns.

Tariff Reimbursement and Future Net Debt Path

The company has filed for tariff reimbursement with a gross effect of roughly EUR 30 million, but management does not include any benefit in its planning given uncertainty on timing and collectability. Looking ahead, net financial debt is expected to rise in 2026 as IFRS lease liabilities increase with a new long‑term distribution center and capex ramps up to EUR 110–130 million from about EUR 103 million.

Guidance and Outlook: Cautious on Margins, Confident on Strategy

For 2026, management expects currency‑neutral net sales growth of 2–6% and an EBIT margin between 5.0% and 7.5%, assuming U.S. duties stay near 2025 levels and FX trims around 1 percentage point from sales and 30–60 basis points from margin. The company plans higher capex while keeping free‑cash‑flow conversion near 100%, reiterates its medium‑term goal to add about 1 percentage point to EBIT margin per year and maintains its ambition for significantly larger defense revenues by 2028.

Draegerwerk’s latest earnings call portrayed a company that has regained financial momentum, combining record sales, stronger margins and healthier cash flow with disciplined capital allocation. While tariffs, FX, rising costs and mixed regional trends still pose risks, management’s cautious guidance and continued investment in innovation and infrastructure suggest a balanced path of measured growth and margin expansion for shareholders.